He will be reporting directly to Biocon Group chairperson, Kiran Mazumdar-Shaw.
Enhance Your Healthcare Expertise with High-Impact Courses
| Offering College | Course | Website |
|---|---|---|
| IIM Kozhikode | IIMK Healthcare Management & Analytics Programme | Visit |
| Indian School of Business | ISB Healthcare Management | Visit |
Bains has stepped down from his role on the Biocon Board as an independent director with immediate effect, to assume this strategic executive responsibility.
“I am delighted to welcome Peter to the Biocon Group in the role of Group CEO. Siddharth Mittal, CEO & MD Biocon Limited, Shreehas Tambe, CEO & MD Biocon Biologics Limited and Jonathan Hunt, CEO & MD Syngene International Limited will continue to have independent charge of their businesses and will work with Peter to strengthen synergistic strategic leadership at a Group level to maximise the combined value of all 3 businesses,” said Mazumdar-Shaw.
Mazumdar-Shaw said Peter has a unique fit and profile for the role having both extensive global leadership experience and success across the biopharmaceutical field and a comprehensive understanding of the Biocon Group, having led Syngene for 5 years, taking it through its very successful IPO in 2015.“I am confident that this appointment will serve the integrated business objectives of the Biocon Group of companies and deliver added value to all stakeholders,” she said.
